Aberrant proplatelet formation in chronic myeloproliferative neoplasms

Leukemia Research

Volumn 34, Issue 11, 2010, Pages 1424-1429

  Muth, Michaela ^a   Büsche, Guntram ^a   Bock, Oliver ^a   Hussein, Kais ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fibrosing and non fibrosing MPN; Megakaryocytes; Primary myelofibrosis; Proplatelets; Pseudopodia

Indexed keywords

GLYCOPROTEIN IB ALPHA;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CANCER; CANCER MORPHOLOGY; CELL DENSITY; CELL PROLIFERATION; CELL SIZE; CHRONIC DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MALE; MEGAKARYOCYTE; MYELOID METAPLASIA; PRIORITY JOURNAL; PSEUDOPODIUM; SEX DIFFERENCE; SYNDROME DELINEATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS; BONE MARROW CELL; CELL SHAPE; MYELOPROLIFERATIVE DISORDER; PATHOLOGY; THROMBOCYTE; THROMBOCYTOPENIA; ULTRASTRUCTURE;

BLOOD PLATELETS; BONE MARROW CELLS; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; HUMANS; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTES; MICROSCOPY, CONFOCAL; MYELOPROLIFERATIVE DISORDERS; PRIMARY MYELOFIBROSIS; PSEUDOPODIA; THROMBOCYTOPENIA;

EID: 77957018733     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.03.040     Document Type: Article

References (27)

1. Schulze H., Shivdasani R.A. Molecular mechanisms of megakaryocyte differentiation. Semin Thromb Hemost 2004, 30:389-398.
2. Pennington D., Streatfield K., Roxburgh A.E. Megakaryocytes and the heterogeneity or circulating platelets. Br J Haematol 1976, 34:639-653.
3. Becker R.P., De Bruyn P.P. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 1976, 145:183-205.
4. Choi E.S., Nichol J.L., Hokom M.M., Hornkohl A.C., Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995, 85:402-413.
5. Italiano J.E.J., Lecine P., Shivdasani R.A., Hartwig J.H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999, 147:1299-1312.
6. Junt T., Schulze H., Chen Z., Massberg S., Goerge T., Krueger A., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007, 317:1767-1770.
7. Thiele J., Titius B.R., Kvasnicka H.M., Rechmeier W., Fischer R. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction. Anal Cell Pathol 1994, 7:63-75.
8. Deutsch V.R., Tomer A. Megakaryocyte development and platelet production. Br J Haematol 2006, 134:453-466.
9. Solberg L.A.J., Tefferi A., Oles K.J., Tarach J.S., Petitt R.M., Forstrom L.A., et al. The effects of anagrelide on human megakaryocytopoiesis. Br J Haematol 1997, 99:174-180.
10. Thiele J., Kvasnicka H.M., Schmitt-Graeff A. Effects of anagrelide on megakaryopoiesis and platelet production. Semin Thromb Hemost 2006, 32:352-361.
11. Thiele J., Kvasnicka H.M., Facchetti F., Franco V., van der Walt J., Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005, 90:1128-1132.
12. Buhr T., Büsche G., Choritz H., Länger F., Kreipe H. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 2003, 119:152-158.
13. Bock O., Höftmann J., Theophile K., Hussein K., Wiese B., Schlué J., et al. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. Am J Pathol 2008, 172:951-960.
14. Büsche G., Georgii A., Kreipe H.H. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies. Histopathology 2006, 48(2):133-148.
15. User manual: True Confocal Scanner Leica TCS SP II. Version 1.4, May 2000; Leica Microsystems Heidelberg GmbH.
16. Patel S.R., Hartwig J.H., Italiano J.E.J. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005, 115:3348-3354.
17. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
18. Andrews R.K., Gardiner E.E., Shen Y., Whisstock J.C., Berndt M.C. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003, 35:1170-1174.
19. Thiele J., Kvasnicka H.M., Amend T., Fischer R. Megakaryocytes and sinus walls in primary osteomyelofibrosis: transendothelial migration as revealed by three-dimensional reconstruction of serial sections following sequential double-immunostaining. Virchows Arch 1994, 424:383-387.
20. Wilkins B.S., Erber W.N., Bareford D., Buck G., Wheatley K., East C.L., et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood 2008, 111:60-70.
21. Patel S.R., Richardson J.L., Schulze H., Kahle E., Galjart N., Drabek K., et al. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood 2005, 106:4076-4085.
22. Wang W., Goswami S., Sahai E., Wyckoff J.B., Segall J.E., Condeelis J.S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15:138-145.
23. Schulze H., Korpal M., Hurov J., Kim S., Zhang J., Cantley L.C., et al. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood 2006, 107:3868-3875.
24. Vitrat N., Cohen-Solal K., Norol F., Guichard J., Cramer E., Vainchenker W., et al. Compared effects of Mpl ligand and other cytokines on human MK differentiation. Stem Cells 1998, 16(Suppl. 2):37-51.
25. Tefferi A., Vardiman J.W. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008, 22:14-22.
26. Chaligné R., James C., Tonetti C., Besancenot R., Le Couédic J.P., Fava F., et al. Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis. Blood 2007, 110:3735-3743.
27. Atallah E., Verstovsek S. Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. Expert Rev Anticancer Ther 2009, 9:663-670.